Lake Street Advisors Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$271K Buy
3,661
+552
+18% +$38.6K 0.01% 480
2024
Q3
$205K Sell
3,109
-722
-19% -$52.5K 0.01% 558
2024
Q2
$354K Buy
3,831
+258
+7% +$22.8K 0.02% 400
2024
Q1
$341K Buy
3,573
+79
+2% +$6.64K 0.02% 428
2023
Q4
$266K Buy
+3,494
New +$243K 0.01% 475
2021
Q3
Sell
-4,436
Closed -$496K 296
2021
Q2
$496K Sell
4,436
-39
-0.9% -$3.68K 0.04% 165
2021
Q1
$374K Buy
4,475
+124
+3% +$10.5K 0.03% 196
2020
Q4
$397K Sell
4,351
-31
-0.7% -$2.57K 0.03% 178
2020
Q3
$350K Sell
4,382
-352
-7% -$27.5K 0.03% 182
2020
Q2
$327K Sell
4,734
-9
-0.2% -$640 0.03% 185
2020
Q1
$298K Buy
4,743
+33
+0.7% +$2.38K 0.04% 176
2019
Q4
$366K Sell
4,710
-42
-0.9% -$3.28K 0.04% 150
2019
Q3
$339K Buy
+4,752
New +$334K 0.04% 133
2019
Q2
Sell
-4,422
Closed -$282K 237
2019
Q1
$282K Sell
4,422
-15
-0.3% -$856 0.03% 162
2018
Q4
$227K Buy
4,437
+936
+27% +$47.4K 0.03% 169
2018
Q3
$203K Buy
+3,501
New +$171K 0.02% 201
2018
Q1
Sell
-5,340
Closed -$201K 330
2017
Q4
$201K Buy
+5,340
New +$196K 0.02% 308

Other funds holding EW

Lake Street Advisors Group's EW Position: Q4 2024 in Review

Lake Street Advisors Group increased its Edwards Lifesciences (EW) stake by 18% in Q4 2024, buying an estimated $38.6K and bringing the position to 3,661 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #480.

Lake Street Advisors Group first reported a position in EW in Q4 2017 and has held it in 17 quarters since. The position peaked at $496K in Q2 2021. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Lake Street Advisors Group held 3,661 shares of Edwards Lifesciences worth $271K as of Q4 2024.
  • Lake Street Advisors Group bought 552 Edwards Lifesciences shares in Q4 2024, an estimated $38.6K.
  • Edwards Lifesciences made up 0.01% of Lake Street Advisors Group's portfolio in Q4 2024, its #480 holding.
  • Lake Street Advisors Group first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 17 quarters since.
  • Lake Street Advisors Group's Edwards Lifesciences position peaked at $496K in Q2 2021.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.